Skip to main content
OpenTrials
Completed

NCT Number: NCT02444208

A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use

Cocaine abuse is an unrelenting public-health concern. Behavioral therapies are considered the "standard of care" for reducing cocaine use and preventing relapse. However, even with intense behavioral interventions, rates of relapse to cocaine use are discouragingly high (i.e., 60-95% of patients return to drug use). Novel strategies are urgently needed to improve treatment outcomes for cocaine-use disorders. The overarching goal of this project is to assess the feasibility, acceptability and initial efficacy of an innovative cocaine-based inhibitory-control training procedure. This goal will be accomplished through the conduct of a Stage I pilot trial. Cocaine-dependent participants will be enrolled and randomized to receive inhibitory-control training to cocaine or neutral images (N=20/condition). This proposed intervention, cocaine based inhibitory-control training, will be delivered using an innovative computer program which teaches cocaine abusers to inhibit a pre-potent response to cocaine or neutral cues. The primary hypothesis is the proposed procedures are feasible and acceptable to the participants. Feasibility will be assessed by determining time needed to enroll the target sample; adaptive randomization outcomes; participant attendance, completion and adherence to study procedures. Acceptability will be determined using a Treatment Acceptability Questionnaire. The secondary hypothesis is that participants receiving cocaine-based inhibitory-control training will reduce their drug use to a greater extent than their counterparts in the neutral-image condition. Reduced cocaine use will be demonstrated by fewer positive-urine samples using qualitative urinalysis and a reduction in levels of benzoylecgonine as determined by quantitative urinalysis (i.e., ELISA). The third hypothesis is that participants receiving cocaine-based inhibitory-control training will show improved inhibitory control and neurocognitive functioning relative to their counterparts in the neutral-image condition. Improved inhibitory control, impulsivity and cognitive functioning will be demonstrated using a battery of clinical instruments and laboratory tasks. The proposed research is highly innovative in that it will provide critical information regarding the feasibility, acceptability, initial efficacy of cocaine-based inhibitory-control training to reduce drug use and improve inhibitory control and neurocognitive functioning in cocaine-dependent participants. Cocaine-based inhibitory control training is also easy to administer (i.e., 15 minutes), inexpensive, need not be administered by a clinician, and could easily be incorporated into current behavioral or community-based treatment approaches to enhance sustained abstinence, thereby quickly impacting clinical research and practice.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky

Lexington, Kentucky, 40507, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Recent cocaine use verified by a cocaine-positive urine sample
  • Meet Cocaine Abuse or Dependence criteria, verified by computerized Structured Clinical Interview for DSM-IV (SCID)
  • Subjects must be seeking treatment for their cocaine use.
  • Subjects must have at least 10% errors in response to cocaine go cues on the ABBA Task at baseline

Exclusion criteria

  • History of serious physical or psychiatric disease that would interfere with study participation
  • Current physical or psychiatric disease that would interfere with study participation
  • Current or past histories of substance abuse or dependence that would interfere with study completion

Treatment and study plan

Active Inhibitory Control Training

Behavioral

Subjects will learn to inhibit responding in the presence of cocaine cues.

Neutral Inhibitory Control Training

Behavioral

Subjects will learn to inhibit responding in the presence of neutral cues.

Primary outcomes

  1. Stop-Signal Task

    Time frame: 8 weeks after study entry

    Response inhibition and response execution will be measured using a stop-signal paradigm using a choice reaction time task that engages participants in responding to go-signals when stop-signals occasionally inform them to inhibit the response.

Secondary outcomes

  1. Retention

    Time frame: 8, 9 and 10 weeks after study entry

    The number of subjects retained through follow up will be determined.

  2. Recruitment

    Time frame: Three years

    The number of subjects recruited into the entire trial will be determined.

  3. Treatment acceptability

    Time frame: 8, 9 and 10 weeks after study

    A patient treatment acceptability questionnaire will be included to determine whether patients find study procedures acceptable.

  4. Protocol Adherence

    Time frame: Three years

    The number of protocol violations across the entire trial will be determined.

  5. Self-Reported Cocaine Use

    Time frame: 7 days

    Self-reported cocaine use will be recorded every 7 days for 10 weeks.

  6. Biologically verified cocaine use

    Time frame: 72 hours

    Cocaine use will be determined using quantitative and qualitative screens at least every 72 hours for 8 weeks.

Sponsors and collaborators

Lead sponsor

University of Kentucky

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Randomized Clinical Trial (01): A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use

Acronym: RCT(01)

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
May 14, 2015
Registry last updated
Jun 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.